- Home
- LMNR vs CATX Comparison
LMNR vs CATX Comparison
Compare LMNR & CATX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LMNR
- CATX
- Stock Information
- Founded
- LMNR 1893
- CATX 1983
- Country
- LMNR United States
- CATX United States
- Employees
- LMNR N/A
- CATX N/A
- Industry
- LMNR Farming/Seeds/Milling
- CATX Medical/Dental Instruments
- Sector
- LMNR Consumer Staples
- CATX Health Care
- Exchange
- LMNR Nasdaq
- CATX Nasdaq
- Market Cap
- LMNR 264.6M
- CATX 239.0M
- IPO Year
- LMNR N/A
- CATX N/A
- Fundamental
- Price
- LMNR $15.10
- CATX $2.99
- Analyst Decision
- LMNR Buy
- CATX Strong Buy
- Analyst Count
- LMNR 2
- CATX 10
- Target Price
- LMNR $20.50
- CATX $12.30
- AVG Volume (30 Days)
- LMNR 59.2K
- CATX 1.6M
- Earning Date
- LMNR 09-09-2025
- CATX 11-10-2025
- Dividend Yield
- LMNR 2.05%
- CATX N/A
- EPS Growth
- LMNR N/A
- CATX N/A
- EPS
- LMNR N/A
- CATX N/A
- Revenue
- LMNR $160,763,000.00
- CATX $1,235,000.00
- Revenue This Year
- LMNR N/A
- CATX N/A
- Revenue Next Year
- LMNR N/A
- CATX N/A
- P/E Ratio
- LMNR N/A
- CATX N/A
- Revenue Growth
- LMNR N/A
- CATX N/A
- 52 Week Low
- LMNR $14.40
- CATX $1.60
- 52 Week High
- LMNR $29.22
- CATX $12.90
- Technical
- Relative Strength Index (RSI)
- LMNR 53.37
- CATX 37.96
- Support Level
- LMNR $14.55
- CATX $2.85
- Resistance Level
- LMNR $15.09
- CATX $5.14
- Average True Range (ATR)
- LMNR 0.35
- CATX 0.49
- MACD
- LMNR 0.04
- CATX -0.18
- Stochastic Oscillator
- LMNR 71.84
- CATX 5.52
About LMNR Limoneira Co
Limoneira Co is predominantly an agribusiness company. Its current operations consist of fruit production and marketing, rental operations, real estate, and capital investment activities. The company has three business divisions; agribusiness, rental operations, and real estate development. The agribusiness division which accounts for a majority of the firm's revenue represents its core operations of farming, harvesting, lemon packing, and lemon sales operations. The company's reportable operating segments are fresh lemons, lemon packing, avocados, and other agribusiness, which predominantly includes oranges, specialty citrus, other crops, and farm management services. A majority of its revenue is derived from the Fresh Lemons segment.
About CATX Perspective Therapeutics Inc.
Perspective Therapeutics Inc is a radiopharmaceutical development company that is pioneering advanced treatment applications for cancers throughout the body. The Company has a proprietary technology that utilizes the alpha-emitting isotope Lead-212 (212Pb) to deliver powerful radiation specifically to cancer cells via specialized targeting moieties.